• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLSTENT-UNI ENDOPROSTHESIS; PROSTHESIS, TRACHEAL, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLSTENT-UNI ENDOPROSTHESIS; PROSTHESIS, TRACHEAL, EXPANDABLE Back to Search Results
Model Number 26650
Device Problems Activation, Positioning or Separation Problem (2906); Material Deformation (2976); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/19/2022
Event Type  Injury  
Event Description
It was reported that stent damage and partial deployment occurred.Vascular access was obtained via the femoral artery.The 60% stenosed, 40x18mm target lesion was located in a non-tortuous and mildly calcified vessel.After a 0.035 x 260cm amplatz super stiff guidewire crossed the lesion, pre-dilatation was performed with a 18mm x 20mm balloon catheter.A 22 x 45mm x 75cm wallstent-uni endoprosthesis stent was advanced, however, the stent did not fully deploy.Even after post -dilatation with a 22mm x 40mm balloon catheter, the proximal end of the stent was still not fully opened and proximal stent edge compression occurred.The physician used another stent to keep the wallstent open and the procedure was completed.No patient complications were reported and the patient status was stable.
 
Manufacturer Narrative
(b5) describe event or problem- correction to the information previously reported.(h6) device codes: corrected from activation, positioning or separation problem to activation failure including expansion failures.
 
Event Description
It was reported that stent damage and stent expansion failure occurred requiring additional intervention.Vascular access was obtained via the femoral artery.The 60% stenosed, 40x18mm target lesion was located in a non-tortuous and mildly calcified vessel.After a 0.035 x 260cm amplatz super stiff guidewire crossed the lesion, pre-dilatation was performed with an 18mm x 20mm balloon catheter.A 22 x 45mm x 75cm wallstent-uni endoprosthesis stent was advanced, however, the stent did not fully deploy.Even after post -dilatation with a 22mm x 40mm balloon catheter, the proximal end of the stent was still not fully opened and proximal stent edge compression occurred.The physician used another stent to keep the wallstent open and the procedure was completed.No patient complications were reported and the patient status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLSTENT-UNI ENDOPROSTHESIS
Type of Device
PROSTHESIS, TRACHEAL, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15319263
MDR Text Key298867617
Report Number2124215-2022-31552
Device Sequence Number1
Product Code JCT
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Model Number26650
Device Catalogue Number26650
Device Lot Number0027936577
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/05/2022
Initial Date FDA Received08/30/2022
Supplement Dates Manufacturer Received09/08/2022
Supplement Dates FDA Received09/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/31/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age40 YR
Patient SexMale
-
-